Private medical technology companies Epiminder and Seer Medical have announced a collaboration to accelerate ultra-long term EEG monitoring so those people who suffer seizures may have an advanced digital therapeutics product to detect and forecast their seizures.
Epiminder is evaluating its Minder ultra-long term EEG implant at St Vincent’s Hospital in Melbourne.
The company said these ultra-long-term EEG recordings produce large data sets and require advanced algorithms and data curation to generate new insights into patient seizure patterns.
"Leveraging Seer Medical’s advanced capabilities in this space will enable, for the first time, specialists in this field to better understand individual patients’ circumstances and medication," said Epiminder in a statement.
According to the University of Melbourne Professor Mark Cook, chair of Medicine at St Vincent’s Hospital Melbourne, “Many people with epilepsy do not achieve adequate control of their seizures. Many of these people live in persistent anxiety and everyday tasks like driving or cooking can become life-threatening. Seer Medical and Epiminder have very complementary technologies that, together, have the potential to dramatically improve epilepsy care.”
Rohan Hoare, CEO of Epiminder said, “This agreement between Seer Medical and Epiminder is poised to accelerate the clinical insight of Minder EEG recordings and potentially add substantial value to our product offering.”
Dean Freestone, CEO of Seer Medical added, “Bringing together the Minder EEG monitor and the Seer Cloud technology, patients will be able to gauge the likelihood of a seizure occurring via an app, bringing back control into people's lives.”